A Single-arm, open-label, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia

Authors
Category Primary study
JournalHaematologica
Year 2017
This article has no abstract
Epistemonikos ID: 4eaf99447284705aca2bc9498b58e8ba5f53d054
First added on: Feb 08, 2025